Anita Treohan has over 14 years of experience in industry and academic clinical research. She brings to ImmusanT an extensive background in global clinical operations and in drug development. Prior to joining, she served in various roles ranging from clinical monitoring to tactical program leads across multiple therapeutic areas and developmental phases. Most recently, Anita was responsible for the operational and early development strategies within CNS indications at FORUM Pharmaceuticals. At Pfizer and GSK, she led several pivotal late-phase programs and championed global training for Clinical Operations at Merck.
Anita earned her BS in Biology from Emory University and her MPH in Epidemiology/Biostatistics and Social Behavioral Sciences from Boston University. Additionally, she maintains certifications in Project Management and Lean Six Sigma.